Translational Development Acquisition TDACU
NASDAQ TDACU
$12.57 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Translational Development Acquisition Corp. (TDACU) Other Operating Expenses (2023)

Translational Development Acquisition's (TDACU) quarterly Other Operating Expenses came in at $485550.0 in Q4 2023.

Translational Development Acquisition Corp. (TDACU) Other Operating Expenses (2023) Analysis & Trends

Translational Development Acquisition (TDACU) has 1 years of Other Operating Expenses data on file, last reported at $485550.0 in Q4 2023.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $485550.0 in Q4 2023, while the trailing twelve-month figure through Mar 2025 was $485550.0 (changed N/A YoY) and the FY2023 annual result came in at $485550.0, changed N/A from the prior year.
  • Other Operating Expenses held at $485550.0 in Q4 2023.
  • In the past five years, Other Operating Expenses ranged from a high of $485550.0 in Q4 2023 to a low of $485550.0 in Q4 2023.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2023 485,550.00